Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team

被引:100
作者
Bleiziffer, Sabine [1 ]
Ruge, Hendrik [1 ]
Mazzitelli, Domenico [1 ]
Schreiber, Christian [1 ]
Hutter, Andrea [1 ]
Laborde, Jean-Claude [1 ]
Bauernschmitt, Robert [1 ]
Lange, Ruediger [1 ]
机构
[1] German Heart Ctr Munich, Cardiovasc Surg Clin, D-80636 Munich, Germany
关键词
Valves; Aortic stenosis; Minimally invasive; Interventional; COREVALVE REVALVING(TM) SYSTEM; HIGH-RISK PATIENTS; SURGERY; OCTOGENARIANS; REPLACEMENT; PROSTHESIS; STENOSIS; OUTCOMES; CARDIOLOGY; STATEMENT;
D O I
10.1016/j.ejcts.2008.12.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Transcatheter aortic valve implantation has been performed by several groups, most of them either specializing on the transapical (surgeons) or the percutaneous femoral transarterial approach (cardiologists). We achieved both transapical and percutaneous transcatheter valve implantation by a surgical team in a hybrid suite. Methods: Since June 2007, 137 patients (n = 78 female, mean age 81 7 years) underwent transcatheter aortic valve implantation (n = 109 transfemoral, n = 3 via subclavian artery, n = 2 directly through ascending aorta, n = 23 transapical) with the CoreValve (n = 114) or the Edwards Sapien (n = 23) prosthesis. Results: Thirty-day mortality was 12.4% in this patient cohort. One hundred and eight patients (78.8%) are alive at a mean follow-up of 97 82 days. Pacemaker implantation due to postoperative AV block was performed in 27 patients (19.7%), and 7 patients (5.1%) sustained neurological events. Patients improved in NYHA class (from 3.1 +/- 0.3 to 1.9 +/- 0.5, p < 0.001) and in self-assessed health state (from 55 +/- 17% to 68 +/- 16%, p < 0.001) at one-month follow-up. Echocardiographic assessment revealed excellent hemodynamic function of the prostheses with a mean aortic gradient (MAG) of 11.9 +/- 4.4 mmHg and an effective orifice area (EOA) of 1.6 +/- 0.4 cm(2) at discharge and a MAG of 11.0 +/- 4.2 mmHg and an EOA of 1.6 +/- 0.3 cm(2) at six months FU. Conclusions: Transcatheter aortic valve implantation has become an alternative technique for the treatment of aortic stenosis with reasonable short- and midterm results at our institution. With the opportunity to treat aortic stenosis by conventional surgical valve replacement and transapical and percutaneous transcatheter procedures, the technique of lowest risk for the individual patient can be chosen and performed by one team. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 21 条
[1]   Valvular surgery in octogenarians: operative risks factors, evaluation of Euroscore and long term results [J].
Collart, F ;
Feier, H ;
Kerbaul, F ;
Mouly-Bandini, A ;
Riberi, A ;
Mesana, TG ;
Metras, D .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 27 (02) :276-280
[2]   Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description [J].
Cribier, A ;
Eltchaninoff, H ;
Bash, A ;
Borenstein, N ;
Tron, C ;
Bauer, F ;
Derumeaux, G ;
Anselme, F ;
Laborde, F ;
Leon, MB .
CIRCULATION, 2002, 106 (24) :3006-3008
[3]  
Eltchaninoff Helene, 2003, J Interv Cardiol, V16, P515, DOI 10.1046/j.1540-8183.2003.01051.x
[4]   High-risk aortic valve replacement: Are the outcomes as bad as predicted? [J].
Grossi, Eugene A. ;
Schwartz, Charles F. ;
Yu, Pey-Jen ;
Jorde, Ulrich P. ;
Crooke, Gregory A. ;
Grau, Juan B. ;
Ribakove, Greg H. ;
Baumann, F. Gregory ;
Ursumanno, Patricia ;
Culliford, Alfred T. ;
Colvin, Stephen B. ;
Galloway, Aubrey C. .
ANNALS OF THORACIC SURGERY, 2008, 85 (01) :102-107
[5]   Percutaneous aortic valve replacement for severe aortic stenosis in high-rick patients using the second- and current third-generation self-expanding CoreValve prosthesis - Device success and 30-day clinical outcome [J].
Grube, Eberhard ;
Schuler, Gerhard ;
Buellesfeld, Lutz ;
Gerckens, Ulrich ;
Linke, Axel ;
Wenaweser, Peter ;
Sauren, Barthel ;
Mohr, Friedrich-Wilhelm ;
Walther, Thomas ;
Zickmann, Bernfried ;
Iversen, Stein ;
Felderhoff, Thomas ;
Cartier, Raymond ;
Bonan, Raoul .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (01) :69-76
[6]   Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease - The Siegburg First-in-Man Study [J].
Grube, Eberhard ;
Laborde, Jean C. ;
Gerckens, Ulrich ;
Felderhoff, Thomas ;
Sauren, Barthel ;
Buellesfeld, Lutz ;
Mueller, Ralf ;
Menichelli, Maurizio ;
Schmidt, Thomas ;
Zickmann, Bernfried ;
Iversen, Stein ;
Stone, Gregg W. .
CIRCULATION, 2006, 114 (15) :1616-1624
[7]   Aortic valve surgery in octogenarians: predictive factors for operative and long-term results [J].
Kolh, Philippe ;
Kerzmann, Arnaud ;
Honore, Charles ;
Comte, Laetitia ;
Limet, Raymond .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (04) :600-605
[8]   First successful transapical aortic valve implantation with the Corevalve Revalving™ System:: A case report [J].
Lange, Ruediger ;
Schreiber, Christian ;
Goetz, Wolfgang ;
Hettich, Ina ;
Will, Albrecht ;
Libera, Paul ;
laborde, Jean-Claude ;
Bauernschmitt, Robert .
HEART SURGERY FORUM, 2007, 10 (06) :E478-E479
[9]   Transapical transcatheter aortic valve implantation in humans - Initial clinical experience [J].
Lichtenstein, Samuel V. ;
Cheung, Anson ;
Ye, Jian ;
Thompson, Christopher R. ;
Carere, Ronald G. ;
Pasupati, Sanjeevan ;
Webb, John G. .
CIRCULATION, 2006, 114 (06) :591-596
[10]  
RICHARDS KL, 1991, CIRCULATION, V84, pI182